Table:
Expression status	Intracellular expression localization	Proteins
Equal expression in both tumour types	Nuclear	VEGFA, TYMP, KDR, KDRp34, FIH, EPHB4, PHD1, SOD1, FGF, P53, SP1, STAT3, MEF2D, JMY, GST, CHGA
Cytoplasm	HIF1, HIF2, VEGFA, TYMP, KDR, KDRp34, FIH, PHD1, SOD1, CXCR4, EPHB4, BCL2, EGF, EGFR, FGF, BNIP3, PI3, SP1, LON, MEF2D, GST, CHGA, SYP
Membrane	CA9, MEF2D
Higher expression in angiogenic tumours than in non-angiogenic tumours in at least one subcellular location	Nuclear	HIF1, PHD2, PHD3, CXCR4, BNIP3, PI3, EGF, FOS
Cytoplasm	PHD2, TSP (stroma), DLL4 (endothelium), FOS, STAT3
Membrane	None
Higher expression in non-angiogenic tumours than in angiogenic tumours in at least one subcellular location	Nuclear	EPHB2, EPHB3,TRAP1
Cytoplasm	CA9, PHD3, EPHB2, EPHB3, NCAM, P53, TRAP1, JMY
Membrane	EPHB3, GST

Render the figure in Markdown format.

| Expression status | Intracellular expression localization | Proteins | 
 | --- | --- | --- | 
 | <ROWSPAN=3> Equal expression in both tumour types | Nuclear | VEGFA, TYMP, KDR, KDRp34, FIH, EPHB4, PHD1, SOD1, FGF, P53, SP1, STAT3, MEF2D, JMY, GST, CHGA | 
 | Cytoplasm | HIF1, HIF2, VEGFA, TYMP, KDR, KDRp34, FIH, PHD1, SOD1, CXCR4, EPHB4, BCL2, EGF, EGFR, FGF, BNIP3, PI3, SP1, LON, MEF2D, GST, CHGA, SYP | 
 | Membrane | CA9, MEF2D | 
 | <ROWSPAN=3> Higher expression in angiogenic tumours than in non-angiogenic tumours in at least one subcellular location | Nuclear | HIF1, PHD2, PHD3, CXCR4, BNIP3, PI3, EGF, FOS | 
 | Cytoplasm | PHD2, TSP (stroma), DLL4 (endothelium), FOS, STAT3 | 
 | Membrane | None | 
 | <ROWSPAN=3> Higher expression in non-angiogenic tumours than in angiogenic tumours in at least one subcellular location | Nuclear | EPHB2, EPHB3,TRAP1 | 
 | Cytoplasm | CA9, PHD3, EPHB2, EPHB3, NCAM, P53, TRAP1, JMY | 
 | Membrane | EPHB3, GST |